MEF2C and acute lymphoblastic leukemia: This interactome analysis predicted high MEF2C and BCL2 activities in patients with ETP-ALL compared with other patients with T-ALL (Supplemental Figure 9, A–C) in line with our earlier results (Figure 1A).